- Home
- CHMI vs ANVS Comparison
CHMI vs ANVS Comparison
Compare CHMI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- ANVS
- Stock Information
- Founded
- CHMI 2012
- ANVS 2008
- Country
- CHMI United States
- ANVS United States
- Employees
- CHMI N/A
- ANVS N/A
- Industry
- CHMI Real Estate Investment Trusts
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- ANVS Health Care
- Exchange
- CHMI Nasdaq
- ANVS Nasdaq
- Market Cap
- CHMI 89.2M
- ANVS 44.6M
- IPO Year
- CHMI 2013
- ANVS 2020
- Fundamental
- Price
- CHMI $2.83
- ANVS $2.36
- Analyst Decision
- CHMI Hold
- ANVS Strong Buy
- Analyst Count
- CHMI 2
- ANVS 4
- Target Price
- CHMI N/A
- ANVS $18.00
- AVG Volume (30 Days)
- CHMI 335.8K
- ANVS 485.7K
- Earning Date
- CHMI 08-07-2025
- ANVS 08-14-2025
- Dividend Yield
- CHMI 21.13%
- ANVS N/A
- EPS Growth
- CHMI N/A
- ANVS N/A
- EPS
- CHMI N/A
- ANVS N/A
- Revenue
- CHMI $27,506,000.00
- ANVS N/A
- Revenue This Year
- CHMI N/A
- ANVS N/A
- Revenue Next Year
- CHMI $54.92
- ANVS N/A
- P/E Ratio
- CHMI N/A
- ANVS N/A
- Revenue Growth
- CHMI 19.59
- ANVS N/A
- 52 Week Low
- CHMI $2.34
- ANVS $1.11
- 52 Week High
- CHMI $3.95
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- CHMI 44.15
- ANVS 48.29
- Support Level
- CHMI $2.68
- ANVS $2.05
- Resistance Level
- CHMI $3.03
- ANVS $3.18
- Average True Range (ATR)
- CHMI 0.08
- ANVS 0.26
- MACD
- CHMI -0.02
- ANVS -0.08
- Stochastic Oscillator
- CHMI 45.71
- ANVS 27.43
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.